References
- Baccarani M. Low doses arabinosylcytosine for treatment of myelodysplastic syndromes and subacute leukemia. Leuk Res 1983; 7: 539–545
- Housset M., Daniel M. T., Degos L. Small dose of Ara-C in the treatment of acute myeloid leukemia: Differentiation of leukemic myeloid cells. Br J Haematol 1981; 51: 125–129
- Castaigne S. Traitement des hemopathies malignes par l'Aracytine a faible dose. Analyse des 159 cas. Nouv Rev Fr Hematol 1985; 27: 377–382
- Perri R. T., Weisdorf D. J., Oken M. M. Low-dose ARA-C fails to enhance differentiation of leukaemic cells. Br J Haematol 1985; 59: 697–701
- Jensen M. K., Ahlbom G. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemia. Scand J Haematol 1985; 34: 261–263
- Hossfeld D. K., Weh H. J., Kleeberg U. R. Low dose cytarabine: Chromosomal findings suggesting its cytostatic as well as differentiating effect. Leuk Res 1985; 9: 329–330
- Robert K. H. Acute myelogenous leukemia of unfavourable prognosis treated with retinoic acid, vitamin D3, alpha-interferon and low doses of cytosine arabinoside. Scand J Haematol 1986; 34: 61–74
- Tilly H. Low dose cyiarabine: Persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia. N Engl J Med 1986; 314: 246–247
- Vecchi V. Impiego dell'Ara-C a basse dosi in una casistica di leucemie acute non linfoidi infantili. XIII Congresso Nazionale Associazione Italiana di Ematologia e Oncologia Pediatrica, Salice Terme (PV), April, 1986, 78, 28–29, (Abstr)
- Cantu-Raynoldi A. Myelodysplastic syndromes in children: Observations on five cases. Pediatr Hematol Oncol 1984; 1: 71–75